Answers are grounded in this paper and cite their sources.
This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
No takes yet. Share an insight, caveat, or question.
Pallavi Ahirrao (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: